Abstract
Background
The survival impact of distal pancreatectomy (DP) with celiac axis resection for locally advanced pancreatic body/tail cancer remains unclear.
Methods
A total of 16 patients underwent DP with celiac axis resection, while 76 underwent standard DP for pancreatic body/tail cancer. The indications for DP with celiac axis resection included: (a) tumor invasion of either the celiac axis or common hepatic artery or both [CA/CHA (+)] and (b) tumor invasion of the root of the splenic artery, which is difficult to dissect without securing an adequate surgical margin [CA/CHA (−)].
Results
DP with celiac axis resection presented longer operative time and greater amount of blood loss than DP. The median survival time was 17.5 months in the DP with celiac axis resection group and 43.1 months in the DP group (p = 0.040). Among the patients who underwent DP with celiac axis resection, the median survival time was 35.1 months in the CA/CHA (−) group and 13.2 months in the CA/CHA (+) group (p = 0.001). Comparing the patients undergoing standard DP and DP with celiac axis resection with a CA/CHA (−) status, there were no significant differences in either disease-free or overall survival times. The CA19-9 value, CA/CHA (+) status, and microscopic venous infiltration were revealed independent significant prognostic factors.
Conclusions
DP with celiac axis resection should therefore be indicated in patients with a CA/CHA (−) status. However, it is difficult to justify the use of DP with celiac axis resection in patients with CA/CHA (+) status due to the poor survival.
Similar content being viewed by others
References
Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427
Appleby LH (1953) The coeliac axis in the expansion of the operation for gastric carcinoma. Cancer 6:704–707
Nimura Y, Hattori T, Miura K et al (1976) Experience of Appleby’s operation for advanced carcinoma of the pancreatic body and tail (in Japanese). Shujutu 30:885–889
Hirano S, Kondo S, Hara T et al (2007) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 246:46–51
Wu X, Tao R, Lei R et al (2010) Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol 17:1359–1366
Takahashi Y, Kaneoka Y, Maeda A et al (2011) Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas. World J Surg 35:2535–2542
Yamamoto Y, Sakamoto Y, Ban D et al (2012) Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 151:61–69
Baumgartner JM, Krasinskas A, Daouadi M et al (2012) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg 16:1152–1159
Okada K, Kawai M, Tani M et al (2013) Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 153:365–372
Jing W, Zhu G, Hu X et al (2013) Distal pancreatectomy with en bloc celiac axis resection for the treatment of locally advanced pancreatic body and tail cancer. Hepatogastroenterology 60:187–190
Cesaretti M, Abdel-Rehim M, Barbier L et al (2016) Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: a major procedure for selected patients. J Visc Surg 153:173–181
Tsuchikawa T, Hirano S, Nakamura T et al (2015) Detailed analysis of extra-pancreatic nerve plexus invasion in pancreatic body carcinoma analyzed by 50 consecutive series of distal pancreatectomy with en-bloc celiac axis resection. Hepatogastroenterology 62:455–458
Beane JD, House MG, Pitt SC et al (2015) Distal pancreatectomy with celiac axis resection: what are the added risks? HPB 17:777–784
Latona JA, Lamb KM, Pucci MJ et al (2016) Modified Appleby procedure with arterial reconstruction for locally advanced pancreatic adenocarcinoma: a literature review and report of three unusual cases. J Gastrointest Surg 20:300–306
Mittal A, de Reuver PR, Shanbhag S et al (2015) Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): common hepatic arterial stump pressure should determine the need for arterial reconstruction. Surgery 157:811–817
Sobin LH, Gospodarowicz MK, Witterkind C (2009) TNM classification of malignant tumors. Wiley, New York
Sugiura T, Uesaka K, Mihara K et al (2013) Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery 154:1078–1086
Butturini G, Stocken DD, Wente MN et al (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75–83 (discussion 83)
Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52–60
Fatima J, Schnelldorfer T, Barton J et al (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:167–172
Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768
Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309
Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345 (discussion 1345–1336)
Ueno H, Ioka T, Ikeda M et al (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 31:1640–1648
Mukherjee S, Hurt CN, Bridgewater J et al (2013) Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol 14:317–326
Nagakawa T, Mori K, Nakano T et al (1993) Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80:619–621
Kayahara M, Nagakawa T, Konishi I et al (1991) Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 10:105–111
Katz MH, Pisters PW, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833–846 (discussion 846–838)
Barugola G, Partelli S, Crippa S et al (2012) Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg 203:132–139
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no financial or any other type of support.
Rights and permissions
About this article
Cite this article
Sugiura, T., Okamura, Y., Ito, T. et al. Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer. World J Surg 41, 258–266 (2017). https://doi.org/10.1007/s00268-016-3670-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-016-3670-3